Cargando…

The Role of “Critical” Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules

Background and Objectives: Bethesda III (BIII) thyroid nodules have an expected malignancy rate of 5–15%. Our purpose was to assess which US criteria are most associated with cancer risk, and the value of critical ultrasound (US) reassessment. Methods: From 2018 to 2022, 298 BIII nodules were enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orlando, Giuseppina, Graceffa, Giuseppa, Mazzola, Sergio, Vassallo, Fabrizio, Proclamà, Maria Pia, Richiusa, Pierina, Radellini, Stefano, Paladino, Nunzia Cinzia, Melfa, Giuseppina, Scerrino, Gregorio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456377/ https://www.ncbi.nlm.nih.gov/pubmed/37629774 http://dx.doi.org/10.3390/medicina59081484

Ejemplares similares

Weight Gain and Asthenia Following Thyroidectomy: Current Knowledge from Literature Review
por: Scerrino, Gregorio, et al.
Publicado: (2022)

Risk Factors for Anaplastic Thyroid Carcinoma: A Case Series From a Tertiary Referral Center for Thyroid Surgery and Literature Analysis
por: Graceffa, Giuseppa, et al.
Publicado: (2022)

Editorial: Recent Advances in Thyroid Surgery
por: Scerrino, Gregorio, et al.
Publicado: (2022)

Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism
por: Graceffa, Giuseppa, et al.
Publicado: (2022)

Predictors of Central Compartment Involvement in Patients with Positive Lateral Cervical Lymph Nodes According to Clinical and/or Ultrasound Evaluation
por: Graceffa, Giuseppa, et al.
Publicado: (2021)

Effects of Intraoperative Nerve Monitoring Techniques on Voice and Swallowing Disorders after Uncomplicated Thyroidectomy: Preliminary Report of a Bi-Institutional Prospective Study
por: Melfa, Giuseppina, et al.
Publicado: (2022)

Papillary Thyroid Microcarcinoma: Active Surveillance Against Surgery. Considerations of an Italian Working Group From a Systematic Review
por: Orlando, Giuseppina, et al.
Publicado: (2022)

Breast cancer in previously thyroidectomized patients: which thyroid disorders are a risk factor?
por: Graceffa, Giuseppa, et al.
Publicado: (2021)

Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review
por: Attard, Andrea, et al.
Publicado: (2019)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Which Role for Hyperbaric Oxygen Therapy in the Treatment of Fournier's Gangrene? A Retrospective Study
por: Tutino, Roberta, et al.
Publicado: (2022)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
por: Chiang, Pi-Ling, et al.
Publicado: (2023)

Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
por: Yoo, Mi Ri, et al.
Publicado: (2015)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules()
por: Alqahtani, Saad M., et al.
Publicado: (2022)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

Managing Bethesda IV thyroid nodules in an iodine-deficient population
por: Badash, Ido, et al.
Publicado: (2023)

Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital
por: Al Dawish, Mohamed, et al.
Publicado: (2020)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

Strain Elastography as a Valuable Diagnosis Tool in Intermediate Cytology (Bethesda III) Thyroid Nodules
por: Stoian, Dana, et al.
Publicado: (2019)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
por: Zahid, Adnan, et al.
Publicado: (2021)

Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
por: Huang, Jianhao, et al.
Publicado: (2021)

Serum Anti-Thyroglobulin Autoantibodies Are Specific in Predicting the Presence of Papillary-like Nuclear Features and Lymphocytic Infiltrate in the Thyroid Gland
por: Cabibi, Daniela, et al.
Publicado: (2023)

Helicobacter pylori and Epstein–Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?
por: Giammanco, Anna, et al.
Publicado: (2023)

A Stepwise Proposal for Low-Grade Hemorrhoidal Disease: Injection Sclerotherapy as a First-Line Treatment and Rubber Band Ligation for Persistent Relapses
por: Tutino, Roberta, et al.
Publicado: (2022)

Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study
por: Kuta, Victoria, et al.
Publicado: (2021)

Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule
por: Li, Fu, et al.
Publicado: (2019)

Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
por: Loderer, Tommaso, et al.
Publicado: (2023)

Association of thiol/disulphide homeostasis with Bethesda classification of thyroid nodules and thyroid cancer
por: BİLGİNER, Muhammet Cüneyt, et al.
Publicado: (2022)

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients with Thyroid Nodules Classified As Bethesda Category III
por: Mileva, Magdalena, et al.
Publicado: (2018)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients
por: Cho, Yoon Young, et al.
Publicado: (2021)

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
por: Hu, Mimi I, et al.
Publicado: (2021)

Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III–V thyroid nodules
por: Talmor, Guy, et al.
Publicado: (2022)

CSI: Bethesda
por: Shaw, Philip
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_s3sh2ap2tb3aakbl622ie2457g